Sapphiros
Niall Armes serves as the Chief Scientific Officer at Biocrucible since September 2020 and has been the Chief Executive Officer of Biocrucible Ltd since August 2019. Previously, Niall held the position of CEO at TwistDx Ltd from November 2002 to May 2018 and worked as a Senior Research Scientist at the Gurdon Institute from November 2000 to November 2002. Earlier roles include a Scientist at the National Institute for Medical Research from October 1995 to November 2000. Niall Armes earned a Doctor of Philosophy in Molecular Biology from the Imperial Cancer Research Fund between 1991 and 1995 and a Bachelor's degree in Genetics from Newcastle University from 1988 to 1991.
This person is not in any offices
Sapphiros
Sapphiros invest in and provide operational support to a select cohort of innovative diagnostics companies.